Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Bio Closes $2.2M Tranche in Private Placement

NEW YORK (GenomeWeb) – Pressure BioSciences announced today that it has closed a roughly $2.2 million tranche of a $5 million private placement, netting approximately $1.3 million.

According to the company, about $1.5 million of the investment was received in cash, with the remainder coming from the conversion of principal and interest on outstanding promissory notes.

Under the terms of the placement, Pressure Bio said that it will issue senior secured convertible debentures with a fixed conversion price of $.28 per restricted common share, as well as common stock purchase warrants exercisable into a total of 3.9 million shares of restricted common stock exercisable at $.40 per share.

Pressure Bio President and CEO Richard Schumacher said in a statement that funds from the tranche will be used to increase the company's marketing and sales headcount, continue building the installed base of instruments and use of consumables, and to retire a significant portion of the variable priced convertible debt previously assumed.

"It is expected that cash received from any additional closings that might occur in the near future will be used to pay off any remaining variable priced convertible debt," he added. 

Pressure Bio said at least one additional tranche may close on or before August 7.

As of March 31, the firm had $220,310 in cash and cash equivalents. When it announced its first quarter financial results in May, Pressure Bio warned of a cash shortage.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.